Dr Peter A Senior

@IsletTx

Type 1 Diabetes & Clinical Islet Transplant Friendocrinologist,
Director, Alberta Diabetes Institute
Charles A. Allard Chair in Diabetes Research

Edmonton, Alberta islet.ca Joined May 2009

268 Following 2.3K Followers 2.9K Posts

Latest posts 5

Dr Peter A Senior @IsletTx Jun 20, 2025

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine nejm.org/doi/full/10.10…

Hope this proves as transformative as the Edmonton Protocol

www.nejm.org Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...

Dr Peter A Senior @IsletTx Jun 20, 2025

Excited to present at #ddata2025 on the future of cell therapies for #T1D
Also on the agenda discussion re GLP1 in T1D @DiabetesCanada has CPGs recommending adjunctive therapy

Dr Peter A Senior @IsletTx Jun 16, 2025

Nerea Cuesta-Gomes presenting at ⁦#ipita2025 in Pisa. Excellent post-doc scientist ⁦@AlbertaDiabetes⁩ ⁦@UAlberta_FoMD⁩

Dr Peter A Senior @IsletTx Jun 9, 2025

Jamie Boisvenue, Class of '25 | Department of Medicine ualberta.ca/en/department-…

www.ualberta.ca Jamie Boisvenue, Class of '25

Dr Peter A Senior @IsletTx Jun 6, 2025

Congrats Farid and colleagues. I was delighted to chair the DSMB and can attest to the rigorous conduct of the study - and the very impressive safety is hugely important

Daniel J Drucker @DanielJDrucker Jun 6, 2025

New over 22 weeks dapagliflozin, as an adjunct to insulin, in youth with #T1D reduced measured eGFR (mGFR) improved glycemic control and was safe when combined with ketone testing and risk mitigation strategies @UHN @NatureMedicine nature.com/articles/s4159… @uoftmedicine
View quoted post on X